Senseonics Holdings Inc. stock trades under the ticker SENS & creates implantable glucose monitoring systems for folks with diabetes.
SENS stock closed at $3.14/share on 8/5/2021, and looks poised to continue climbing higher on technical strength.
SENS Stock Price: $3.14
10 Day Moving-Average: $3.06
50 Day Moving-Average: $3.17
200 Day Moving-Average: $2.16
RSI: 51
MACD: -0.029
Yesterday SENS completed a bullish MACD crossover, a signal of technical strength.
In addition to their MACD crossover, the 10 Day Moving-Average is ~3% away from crossing the 50 Day MA, which will help propel the price higher.
Most importantly, the RSI is neutral, showing that their share price is neither overbought, nor oversold.
Senseonics Holdings Inc.’s stock has traded on below average volume recently, while being constricted to a tight price range since July.
SENS options look to be very liquid, with all of of the at-the-money range calls & puts having good volume of Open Interest.
However, their implied volatility is high, which may make some options traders more likely to want to sell vs. buy.
I am looking at the $3 & $3.50 strike prices, over the 8/20 & 9/17 expiration dates.
These seem to be a realistic range for that time period, unlike the $4 calls.
From a long-term traders perspective, SENS stock looks to continue climbing.
While it does not have a positive P/E (ttm), their chart looks to have long-term positive momentum.
Furthermore, with how many people are impacted by the disease that they are fighting, there is great opportunity for growth as the company matures & solves their problems.
Overall, SENS stock looks to be an interesting opportunities for both long-term & short-term traders alike & is worth taking a closer look at.
*** I DO NOT OWN SHARES OF SENS STOCK ***